Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis

Completed · Phase 4

Conditions studied: Allergic Conjunctivitis

In brief

The purpose of this study is to compare the effects of two marked ocular anti-allergy medications in cat sensitive subjects with allergic conjunctivitis.

Key facts

Study ID

NCT00534794

Run by

Merck Sharp & Dohme LLC

People needed

79

Starts

2007-10-01

Last updated by the study team

2015-05-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Documented history of ocular allergy to cats.
• Positive skin prick allergen reaction to cat dander.

You may not qualify if…

• Use of any topical or systemic corticosteroids, immunosuppressive agents, antihistamines, decongestants, NSAIDs, or asprin during the two weeks prior to enrollment into the study.
• History of severe asthma, reactive airway disease or bronchial obstruction.
• Ocular surgery or trauma in the last year.

Where it is running

• Ophthalmic Consultants of Boston — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.